Digital Transformation in Health Care: Are We on the Right Track?

• by Guilherme Tortorella, Flavio Fogliatto, Roberto Vassolo, Alejandro Mac Cawley, Diego Tlapa

• July 21, 2026

FDA Approves First Oral PCSK9 Inhibitor

Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.

• by Kathryn Wighton

• July 16, 2026

• 2 min

Associated factors and a risk prediction model for comorbid circadian rhythm sleep-wake disorders in patients with chronic fatigue syndrome: implications for early screening and sleep health management

• by Xiao Shao, Fan Yang, Le-le Qin, Jia-ning Shi, Min Chen, Wen-jin Ge, Tian-jun Jiang, Jing-wen Yue, Wen Feng, Jing-han Wang, Zhen-xian Zhang

• July 20, 2026

Assessing the diagnostic accuracy of cardisiography in the diagnosis of coronary heart disease: CSG-DR study (A pilot study)

• by Rafael A. Guillén-Marmolejos, Rodolfo A. Núñez-Musa, Alberto J. Núñez-Selles, Ana J. Santos-Rondón, Miguel Arias-Ceballos, the CSG Group

• July 21, 2026